deltatrials
Terminated PHASE1 INTERVENTIONAL 2-arm NCT02350426

A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

An Adaptive Design Open Label Pilot Study in Rheumatoid Arthritis Patients to Assess Inflammation Using Molecular Imaging Techniques

Sponsor: Cambridge University Hospitals NHS Foundation Trust

Conditions Arthritis, Rheumatoid
Interventions 18F-FDG 18F-GE-180 Gadobutrol
Updated 10 times since 2017 Last updated: Dec 1, 2017 Started: Aug 12, 2015 Primary completion: Oct 26, 2016 Completion: Oct 26, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

A decision to stop the study was made by the site and GSK project team based on pre-defined stopping criteria in the protocol

Other terminated trials from Cambridge University Hospitals NHS Foundation Trust

See all terminations from Cambridge University Hospitals NHS Foundation Trust

Other Arthritis, Rheumatoid trials with similar outcome

Browse all Arthritis, Rheumatoid trials

A PHASE1 clinical study on Arthritis, Rheumatoid, this trial is terminated or withdrawn. The trial is conducted by Cambridge University Hospitals NHS Foundation Trust and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshotTerminated~Dec 2017 – ~May 2018 · 5 months · monthly snapshotTerminated~May 2018 – ~Jun 2018 · 31 days · monthly snapshotTerminated~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotTerminated~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE1

  5. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE1

▶ Show 5 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Terminated PHASE1

  2. May 2018 — Jun 2018 [monthly]

    Terminated PHASE1

  3. Dec 2017 — May 2018 [monthly]

    Terminated PHASE1

  4. Feb 2017 — Dec 2017 [monthly]

    Terminated PHASE1

    Status: Completed → Terminated

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cambridge University Hospitals NHS Foundation Trust
  • GlaxoSmithKline
Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations